Why Do CDI Directors love Iodine Software’s Forecast Module?

 

Artificial intelligence is increasingly pivotal in healthcare, improving patient outcomes and healthcare professionals’ work efficacy. One technology making waves in this domain is Iodine Software’s Forecast module, a tool designed to enhance Clinical Documentation Integrity (CDI) by automating dynamic elements of the process. Given the global mid-revenue cycle management/clinical documentation market’s expected reach of $4.55 billion by 2027, the stakes are high for healthcare organizations to ensure accuracy and efficiency in their documentation practices.

Why is Iodine Software’s Forecast module consistently rated as a top product among customers in the healthcare industry? What makes it stand out in a healthcare market teeming with technological advancements in AI?

Sheila Duhon, Director of Clinical Documentation Integrity at Steward Healthcare, shared why Iodine’s Forecast ranks number one on her list.

During this customer testimonial video, Duhon discusses:

  • How Forecast was born out of a need to maintain CDI specialists within their scope and how it facilitates this
  • The way Forecast assists in managing the “moving target” of the working Diagnosis-Related Group (DRG), a key variable that can change throughout the day
  • The overall impact of Forecast on the purity and efficiency of CDI and how it has transformed the workflow for CDI specialists at Steward Healthcare

Sheila Duhon, a seasoned healthcare professional, is the Director of Clinical Documentation Integrity at Steward Healthcare, one of the largest private, physician-led healthcare networks in the United States. With a background in nursing, Duhon has been instrumental in driving advancements in CDI and is known for her customer-centric approach. Under her leadership, Steward Healthcare has partnered with Iodine Software to develop and implement solutions like Forecast, further solidifying its commitment to technological innovation in healthcare.

Recent Episodes

In this impactful episode of the ConCensis podcast, host Yasmeen Hassan sits down with Robby Miller, Sterile Processing Manager at St. Joseph’s Hospital Medical Center, to explore how artificial intelligence is revolutionizing the field of sterile processing. With nearly 30 years of experience in healthcare, Miller shares his journey from EMT to SPD leader, offering…

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…